Home Current Issue Previous Issues Podcasts Online First ASA Practice Parameters CME For Authors Journal Info
Skip Navigation LinksHome > April 2011 - Volume 114 - Issue 4 > Perioperative Smoking Risk
Anesthesiology:
doi: 10.1097/ALN.0b013e318210fedc
Editorial Views

Perioperative Smoking Risk

Katznelson, Rita M.D.; Beattie, W. Scott M.D., Ph.D., F.R.C.P.C.

Free Access
Article Outline
Collapse Box

Author Information

THE tobacco epidemic represents a significant preventable cause of death and is probably the greatest health disaster in human history, being associated with more than 5 million deaths annually. Tobacco dependence is also, arguably, the most difficult dependency to break and often requires repeated interventions and attempts to quit.1 A mounting body of evidence has led to the following two important conclusions. (1) Smoking harms nearly every organ of the body, causing many diseases and reducing smokers' health in general. (2) Quitting smoking has long-term benefits by reducing risks for diseases caused by smoking.2
In this edition of Anesthesiology, Turan et al.,3 from the Cleveland Clinic, Cleveland, Ohio, conducted an analysis of the American College of Surgeons National Surgical Quality Improvement Program Database of more than 600,000 patients. The results of this important work found that smokers had a higher mortality and increased rates of all cardiorespiratory and septic complications. The investigation details a propensity score–matched cohort comparison of current smokers, defined as “patients who reported smoking cigarettes in the year before admission for surgery,” with a cohort of patients who reported a “zero lifetime pack-years.” These definitions are important to recognize because the reported analysis excluded patients who had managed to break their tobacco dependency. Irrespectively, this study is an important addition to the literature because previous studies, linking smoking to poor outcomes, were limited by small sample sizes, single institutions, and limited follow-up.
In all observational research, it is important to recognize the potential limitations of the analysis. In the study by Turan et al.,3 the authors did not adjust for the known, or suspected, comorbidities associated with long-term tobacco use, arguing that to adjust for these “confounders,” such as chronic obstructive pulmonary disease and coronary disease, would “match away” the long-term effects of smoking. Although this method can be justified at some level, readers should understand that this is a form selection bias and that patients with coronary disease who never smoked would tend to be underrepresented in the analysis. This decision would tend to bias the end result and overestimate the risk of smoking. Furthermore, as the authors have noted, it is also likely the effects of smoking are overestimated because of the opposite of a healthy user effect. In this case, adjustment of the confounders cannot account for behaviors that are associated with smoking, such as increasing alcohol consumption, or minimal use of primary medical care.
However, this analysis has many strengths; most important, it is an analysis of a large population across many locations and is, thus, generalizable to most practices. Observational studies are seldom linked to causality, yet this analysis retains many elements of the Bradford Hill criteria for causality. These criteria for causation are a group of minimal conditions necessary to provide adequate evidence of a causal relationship between an incidence and a consequence. These criteria include the following: (1) strength of an association, (2) consistency, (3) specificity, (4) temporal relationship, (5) dose–response relationship, (6) biological plausibility, (7) coherence, (8) reversibility, and (9) consideration of alternate explanations. Even after accounting for the inherent bias, the article demonstrates a strong association between smoking history and adverse postoperative outcomes. The results are consistent with those of previous publications on cardiac,4 vascular,5 thoracic,6 general,7 urologic,8 and plastic reconstructive surgical procedures.9 There is a clear temporal relationship demonstrated. Furthermore, two figures (figures 3 and 4 in the article by Turan et al.3) demonstrate a clear and significant dose–response between amount smoked and adverse surgical outcomes.
The association between smoking and major adverse surgical events is biologically plausible. Nicotine induces hypertension and tachycardia through its effect on the sympathetic nervous system.10,11 In addition, carbon monoxide (the concentration of which also bears a dose–response relationship with amount smoked) substitutes oxygen in the molecule of hemoglobin, shifts the oxygen–hemoglobin dissociation curve to the left, and decreases oxygen availability to the tissues.12 The net effect of these interactions impairs oxygen delivery, leading to tissue ischemia. Tobacco use damages cilia, increases mucus production, impairs clearing of secretions, and renders the bronchial tree irritable,13 leading to sputum retention,14 pneumonia, and respiratory failure.15 Cigarettes inhibit immune function, resulting in delayed wound healing and infection.16,17 Smokers have abnormal bone metabolism and may experience delayed fracture healing.18,19 Smoking has a direct effect on the central nervous system, affecting pain perception20 and opiate requirements.21
Unfortunately, and as previously noted, the current study does not address smoking cessation (or reversibility) in either the long-term or the immediate preoperative period. The analysis was a restricted comparison between current smokers and patients who had a zero pack-year history; thus, all patients who have managed to quit for longer than 1 yr were excluded. Because smoking has been identified as a significant independent risk factor for postoperative morbidity, we believe the most important issue is as follows: Does an intervention that decreases the number of patients who smoke (or the amount smoked) result in better postoperative outcomes? There is no debate that smoking cessation is beneficial, in the long-term, and that many of the detrimental physiologic effects of smoking are reversible after smoking cessation.22,23 For the perioperative physician, the real issue is when the optimal timing of preoperative smoking cessation is unknown.
Prolonged abstinence from smoking significantly decreases the risk of postoperative respiratory complications.13,24 Six months of abstinence restores antimicrobial and inflammatory alveolar macrophage function.25 Smoking cessation for 6–8 weeks improves pulmonary function26 and decreases wound-related and cardiovascular complications.27 Three weeks of abstinence reduced the incidence of impaired wound healing.28
Every smoker undergoing surgery is in various states of recovery (withdrawal) from the effects of tobacco. However, the acute phases of this process are poorly understood. The available evidence on the effects of sudden withdrawal is contradictory and highlights the need for more high-quality investigation of the problem. Theoretically, at least, abstinence for 1 day could reduce nicotine (half-life, 1 h) and carboxyhemoglobin (half-life, 4 h) concentrations and, thus, may be long enough to decrease blood concentrations and improve tissue oxygen delivery.13 Alternatively, observational data suggest that abstinence from cigarettes may exacerbate preoperative stress,29 although many smokers do not experience nicotine withdrawal symptoms. Many investigators believe the postoperative period is an excellent opportunity to reinforce abstinence, especially in the hospital setting, where “no smoking” policies are almost universal. However, several other studies30,31 have suggested that pulmonary complications may be exacerbated in patients suddenly withdrawing from tobacco. These trials have a small sample size and all manner of bias inherent to observational trials. We should not ignore the possibility that, in the short-term, smoking cessation may increase pulmonary complications; the inability to clear increased pulmonary secretions makes this finding biologically plausible. Again, it is evident that high-quality investigations, powered to show meaningful results and using the appropriate end points, must be conducted.
It seems that the need for surgery increases the likelihood of successful smoking cessation and confirms the concept that surgery and perioperative events create a “teachable moment” in a smoker's life.32 The American Society of Anesthesiologists–sponsored Smoking Cessation Initiative Task Force has recommended that anesthesiologists use the Ask–Advise–Refer strategy that is designed to identify current smokers, advise them to quit, and refer them to the free national telephone quit line for further support. Strategies such as this are potentially feasible and should be accepted as policy in every preoperative assessment clinic.33 Interventions that begin 4–8 weeks before surgery include weekly follow-ups, and nicotine replacement therapy seems to be efficient in terms of both postoperative complications and long-term smoking cessation.34 However, in many situations, a delay in surgery of up to 4 weeks, to facilitate these pathophysiologic improvements, is not feasible; surgical delays of this duration have been linked to increased morbidity.35 There are simply not enough data to confirm that a brief intervention immediately before surgery results in a reduction in postoperative morbidity.36
Turan et al.3 have increased our knowledge by showing that smoking increases perioperative morbidity, in a dose-related manner. Anesthesiologists are uniquely positioned at the crossroads of patient willingness to quit, institutional policy, and societal programs, whose primary intention is to stop smoking. As a profession, we should take a leadership role and influence this major public health epidemic. We should embrace the various smoking cessation initiatives, use this opportunity to comprehensively study the issues related to smoking cessation, and establish the optimal methods and timing for preoperative cessation and the effects these have on postoperative outcomes.
Rita Katznelson, M.D.
W. Scott Beattie, M.D., Ph.D., F.R.C.P.C.
Department of Anaesthesia and Pain Management, University of Toronto, University Health Network, Toronto, Ontario, Canada. scott.beattie@uhn.on.ca
Back to Top | Article Outline

References

1. 2008 PHS Guideline Update Panel, Liaisons, and Staff: Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care 2008; 53:1217–22

2. The 2004 United States Surgeon General's Report: The Health Consequences of Smoking. N S W Public Health Bull 2004; 15:107

3. Turan A, Mascha EJ, Roberman D, Turner PL, You J, Kurz A, Sessler DI, Saager L: Smoking and perioperative outcomes. Anesthesiology 2011; 114:837–46

4. Jones R, Nyawo B, Jamieson S, Clark S: Current smoking predicts increased operative mortality and morbidity after cardiac surgery in the elderly. Interact Cardiovasc Thorac Surg 2011; 12:449–53

5. Johnson RG, Arozullah AM, Neumayer L, Henderson WG, Hosokawa P, Khuri SF: Multivariable predictors of postoperative respiratory failure after general and vascular surgery: Results from the patient safety in surgery study. J Am Coll Surg 2007; 204:1188–98

6. Groth SS, Whitson BA, Kuskowski MA, Holmstrom AM, Rubins JB, Kelly RF: Impact of preoperative smoking status on postoperative complication rates and pulmonary function test results 1-year following pulmonary resection for non-small cell lung cancer. Lung Cancer 2009; 64:352–7

7. Delgado-Rodriguez M, Medina-Cuadros M, Martínez-Gallego G, Gómez-Ortega A, Mariscal-Ortiz M, Palma-Pérez S, Sillero-Arenas M: A prospective study of tobacco smoking as a predictor of complications in general surgery. Infect Control Hosp Epidemiol 2003; 24:37–43

8. Hahn RG: Smoking increases the risk of large scale fluid absorption during transurethral prostatic resection. J Urol 2001; 166:162–5

9. Goodwin SJ, McCarthy CM, Pusic AL, Bui D, Howard M, Disa JJ, Cordeiro PG, Mehrara BJ: Complications in smokers after postmastectomy tissue expander/implant breast reconstruction. Ann Plast Surg 2005; 55:16, 19; discussion, 19–20

10. Narkiewicz K, van de Borne PJ, Hausberg M, Cooley RL, Winniford MD, Davison DE, Somers VK: Cigarette smoking increases sympathetic outflow in humans. Circulation 1998; 98:528–34

11. Pickering TG, Schwartz JE, James GD: Ambulatory blood pressure monitoring for evaluating the relationships between lifestyle, hypertension and cardiovascular risk. Clin Exp Pharmacol Physiol 1995; 22:226–31

12. Rietbrock N, Kunkel S, Worner W, Eyer P: Oxygen-dissociation kinetics in the blood of smokers and non-smokers: Interaction between oxygen and carbon monoxide at the hemoglobin molecule. Naunyn Schmiedebergs Arch Pharmacol 1992; 345:123–8

13. Warner DO: Perioperative abstinence from cigarettes: Physiologic and clinical consequences. Anesthesiology 2006; 104:356–67

14. Bonde P, McManus K, McAnespie M, McGuigan J: Lung surgery: Identifying the subgroup at risk for sputum retention. Eur J Cardiothorac Surg 2002; 22:18–22

15. Dilworth JP, White RJ: Postoperative chest infection after upper abdominal surgery: An important problem for smokers. Respir Med 1992; 86:205–10

16. McAllister-Sistilli CG, Caggiula AR, Knopf S, Rose CA, Miller AL, Donny EC: The effects of nicotine on the immune system. Psychoneuroendocrinology 1998; 23:175–87

17. Bartsch RH, Weiss G, Kastenbauer T, Patocka K, Deutinger M, Krapohl BD, Benditte-Klepetko HC: Crucial aspects of smoking in wound healing after breast reduction surgery. J Plast Reconstr Aesthet Surg 2007; 60:1045–9

18. Fung YK, Iwaniec U, Cullen DM, Akhter MP, Haven MC, Timmins P: Long-term effects of nicotine on bone and calciotropic hormones in adult female rats. Pharmacol Toxicol 1999; 85:181–7

19. W-Dahl A, Toksvig-Larsen S: Cigarette smoking delays bone healing: A prospective study of 200 patients operated on by the hemicallotasis technique. Acta Orthop Scand 2004; 75:347–51

20. Shi Y, Weingarten TN, Mantilla CB, Hooten WM, Warner DO: Smoking and pain: Pathophysiology and clinical implications. Anesthesiology 2010; 113:977–92

21. Creekmore FM, Lugo RA, Weiland KJ: Postoperative opiate analgesia requirements of smokers and nonsmokers. Ann Pharmacother 2004; 38:949–53

22. Swan GE, Hodgkin JE, Roby T, Mittman C, Jacobo N, Peters J: Reversibility of airways injury over a 12-month period following smoking cessation. Chest 1992; 101:607–12

23. Critchley J, Capewell S: Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2004; (1):CD003041

24. Theadom A, Cropley M: Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: A systematic review. Tob Control 2006; 15:352–8

25. Kotani N, Kushikata T, Hashimoto H, Sessler DI, Muraoka M, Matsuki A: Recovery of intraoperative microbicidal and inflammatory functions of alveolar immune cells after a tobacco smoke-free period. Anesthesiology 2001; 94:999–1006

26. Buist AS, Sexton GJ, Nagy JM, Ross BB: The effect of smoking cessation and modification on lung function. Am Rev Respir Dis 1976; 114:115–22

27. Møller AM, Villebro N, Pedersen T, Tønnesen H: Effect of preoperative smoking intervention on postoperative complications: A randomised clinical trial. Lancet 2002; 359:114–7

28. Kuri M, Nakagawa M, Tanaka H, Hasuo S, Kishi Y: Determination of the duration of preoperative smoking cessation to improve wound healing after head and neck surgery. Anesthesiology 2005; 102:892–6

29. Warner DO, Patten CA, Ames SC, Offord K, Schroeder D: Smoking behavior and perceived stress in cigarette smokers undergoing elective surgery. Anesthesiology 2004; 100:1125–37

30. Bluman LG, Mosca L, Newman N, Simon DG: Preoperative smoking habits and postoperative pulmonary complications. Chest 1998; 113:883–9

31. Nakagawa M, Tanaka H, Tsukuma H, Kishi Y: Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery. Chest 2001; 120:705–10

32. Shi Y, Warner DO: Surgery as a teachable moment for smoking cessation. Anesthesiology 2010; 112:102–7

33. Thomsen T, Villebro N, Moller AM: Interventions for preoperative smoking cessation. Cochrane Database Syst Rev 2010; (7):CD002294

34. Warner DO; American Society of Anesthesiologists Smoking Cessation Initiative Task Force: Feasibility of tobacco interventions in anesthesiology practices: A pilot study. Anesthesiology 2009; 110:1223–8

35. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, Pierpont G, Santilli S, Rapp J, Hattler B, Shunk K, Jaenicke C, Thottapurathu L, Ellis N, Reda DJ, Henderson WG: Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004; 351:2795–804

36. Thomsen T, Tonnesen H, Okholm M, Kroman N, Maibom A, Sauerberg ML, Møller AM: Brief smoking cessation intervention in relation to breast cancer surgery: A randomized controlled trial. Nicotine Tob Res 2010; 12:1118–24

† WHO report on the global tobacco epidemic, 2008: the MPOWER package. Available at: http://www.who.int/tobacco/mpower/mpower_report_full_2008.pdf. Accessed December 21, 2010. Cited Here...
‡ Similar initiatives are also underway in Canada. See Stop Smoking for Safer Surgery. Available at: http://www.ontarioanesthesiologists.ca/stopsmoking/. Accessed December 21, 2010. Cited Here...

© 2011 American Society of Anesthesiologists, Inc.

Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.
Login

Article Tools

Share